Jake Mintz and Jordan Shusterman dig into what is going wrong with the Yankees, who was selected as an All-Star starter and ...
The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by ...
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
The Food and Drug Administration on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company announced, clearing the way ...
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
Eli Lilly & Co.’s Alzheimer’s treatment was cleared in the US as the second drug to slow progression of the mind-robbing ...